| Jennifer Elizabeth Ding, OD | |
|
2007 Irving St, San Francisco, CA 94122-1715 | |
| (415) 564-1818 | |
| Not Available |
| Full Name | Jennifer Elizabeth Ding |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 2007 Irving St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003337486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT33735TGL (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Elizabeth Ding, OD 722 Jean St, Oakland, CA 94610-1435 Ph: (510) 928-5601 | Jennifer Elizabeth Ding, OD 2007 Irving St, San Francisco, CA 94122-1715 Ph: (415) 564-1818 |
News Archive
Politico reports on how the Obama administration's decision may create some difficulties for employers. Other media outlets detail how Republicans will try to capitalize on it this week on Capitol Hill.
Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune responses in human skin tissue samples.
Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage.
Sens. Dianne Feinstein (D-Calif.) and Olympia Snowe (D-Maine) on Friday sent a joint letter to acting FDA Commissioner Andrew von Eschenbach asking the agency to launch a full review into whether Santa Barbara, Calif.-based Mentor intentionally withheld safety data on its silicone breast implant application, CQ HealthBeat reports (CQ HealthBeat, 10/23).
A study led by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Colorectal cancer is the cancer of the large intestine (colon and rectum) and is the most common cancer in Singapore.
› Verified 1 days ago
Daniel Situ, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 100 Battery St, San Francisco, CA 94111 Phone: 415-399-1573 | |
Opt Optometric Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1415 Valencia St, San Francisco, CA 94110 Phone: 415-572-5500 | |
Geri Cheng, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3518 Balboa St, San Francisco, CA 94121 Phone: 415-386-3937 | |
Bruce Gary Dong, OPTOMETRIST Optometrist Medicare: Not Enrolled in Medicare Practice Location: 619 Irving St, San Francisco, CA 94122 Phone: 415-661-8253 Fax: 415-661-2490 | |
Philip Tawil, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2049 Oak St Apt 1, San Francisco, CA 94117 Phone: 415-431-2988 | |
Leona Landers, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Howard St, Suite B, San Francisco, CA 94105 Phone: 415-908-2733 |